Old Mission Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Old Mission Capital's XBI Position: Q1 2025 in Review
Old Mission Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 13,904 shares — an estimated $1.25M sold.
Old Mission Capital first reported a position in XBI in Q4 2016 and held it in 15 quarters. The position peaked at $8.2M in Q3 2020. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.
- Old Mission Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
- Old Mission Capital sold 13,904 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $1.25M.
- Old Mission Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 15 quarters.
- Old Mission Capital's State Street SPDR S&P Biotech ETF position peaked at $8.2M in Q3 2020.
- 685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.
Based on Old Mission Capital's 13F filing for Q1 2025, filed 15 May 2025.